S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94

Probiotec Stock Forecast, Price & News

Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume26,253 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend Yield2.23%

Receive PBP News and Ratings via Email

Sign-up to receive the latest news and ratings for Probiotec and its competitors with MarketBeat's FREE daily newsletter.

About Probiotec

Probiotec Limited engages in the development, manufacture and sale of pharmaceuticals, consumer health, and nutraceutical products in Australia and internationally. The company provides contract manufacturing services for solid dose tablets, capsules, and caplets; tablets coating; blister packing; liquids, creams, gels, and ointments and suspensions; powders and powder blending; and sprays, as well as manufacturing and packaging of finished doses. It also offers analytical and stability testing services; new product formulation and production trials, and ongoing research and development services; and packaging options for human and animal nutrition products, as well as manufactures and exports a range of nutraceuticals and functional ingredient raw materials. In addition, the company provides packing services and formats, including foil, carded and clamshell blister packing, bottle filling, labelling, secondary packaging, and other services for the pharmaceutical, cosmetic, and food industries. Probiotec Limited was incorporated in 1996 and is headquartered in Laverton North, Australia.


See More Headlines

Industry, Sector and Symbol

Drug Manufacturers - Specialty & Generic
Year Founded

Sales & Book Value

Annual Sales
$120.51 million
Book Value
A$0.87 per share





Next Earnings Date
Not Optionable


Overall MarketRank

1.10 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.7Dividend Strength: 0.8Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Probiotec (ASX:PBP) Frequently Asked Questions

What stocks does MarketBeat like better than Probiotec?

Wall Street analysts have given Probiotec a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Probiotec wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How were Probiotec's earnings last quarter?

Probiotec Limited (ASX:PBP) posted its quarterly earnings data on Tuesday, February, 26th. The company reported $0.02 EPS for the quarter.
View Probiotec's earnings history

How often does Probiotec pay dividends? What is the dividend yield for Probiotec?

Probiotec declared a Final dividend on Thursday, August 26th. Investors of record on Thursday, October 7th will be paid a dividend of 0.03 per share on Thursday, October 7th. This represents a dividend yield of 1.31%. The ex-dividend date of this dividend is Wednesday, September 29th.
View Probiotec's dividend history

Is Probiotec a good dividend stock?

Probiotec pays an annual dividend of A$0.05 per share and currently has a dividend yield of 2.23%. The dividend payout ratio of Probiotec is 81.97%. Payout ratios above 75% are not desirable because they may not be sustainable.
View Probiotec's dividend history.

Who are Probiotec's key executives?

Probiotec's management team includes the following people:
  • Mr. Wesley Stringer B.Comm, LLB (Hons), CPA, CEO, MD & Exec. Director
  • Mr. Jared Stringer B.Comm, BIT, CPA, CFO, Company Sec. & Financial Controller
  • Ms. Julie McIntosh, Chief Operating Officer
  • Mr. Alan Hong, Gen. Mang. of Accounting
  • Mr. Dustin Stringer, Gen. Mang. of Marketing

What other stocks do shareholders of Probiotec own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Probiotec investors own include Kalium Lakes (KLL) and 5G Networks (5GN).

What is Probiotec's stock symbol?

Probiotec trades on the ASX under the ticker symbol "PBP."

How much money does Probiotec make?

Probiotec has a market capitalization of $0.00 and generates $120.51 million in revenue each year.

What is Probiotec's official website?

The official website for Probiotec is www.probiotec.com.au.

How can I contact Probiotec?

The company can be reached via phone at 61 3 9278 7555.

This page was last updated on 10/16/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.